Marylyn Rigby

Marylyn Rigby currently serves as the Chief Communications Officer (CCO) at Sernova, a position held since October 2024. Prior to this role, Marylyn was the Chief Executive Officer at Bioceptive from March 2024 to November 2024. At Revolo Biotherapeutics, Marylyn worked from October 2020 to November 2024, advancing from Vice President Marketing & Investor Relations to Sr. Vice President Marketing and Investor Relations. Marylyn also held the role of Sr. Director Marketing & Investor Relations at United Therapeutics Corporation from October 2019 to October 2020. Earlier in the career, Marylyn served as Sr. Director of Marketing & Investor Relations and Director of Marketing & Investor Relations at SteadyMed Therapeutics from January 2012 to October 2019. Marylyn's career began at CyDex Pharmaceuticals, where responsibilities included Business Development & Marketing from February 2008 to August 2010.